dna methyltransferase inhibitors (dnmtis)

What are the benefits of DNMTis in cancer treatment?

The primary benefit of DNMTis is their ability to reactivate tumor suppressor genes, which can lead to reduced tumor growth and proliferation. Additionally, DNMTis can enhance the effectiveness of other therapies, including immunotherapy and chemotherapy, by altering the tumor microenvironment and making cancer cells more susceptible to immune attack or drug-induced cell death. DNMTis also have a relatively favorable side effect profile compared to traditional chemotherapy agents.

Frequently asked queries:

Partnered Content Networks

Relevant Topics